Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidates include CT-2401, ...
The Canada Border Services Agency (CBSA) has made an amendment to Customs Notice 25-23, expanding contingency measures to cover all goods at sufferance warehouses for 30 days beginning July 10.
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results